0

reloj de arena historia 150pxSpecific immunotherapy in asthma: efficacy and safety
G. Passalacqua and G. W. Canonica. Clinical & Experimental Allergy. Published online: 24 JAN 2011

0

reloj de arena historia 150pxAllergen-specific immunotherapy for respiratory allergies: From meta-analysis to registration and beyond
Moisés A. Calderón, Thomas B. Casale, Alkis Togias, Jean Bousquet, Stephen R. Durham, Pascal Demoly. Journal of Allergy and Clinical Immunology. Volume 127, Issue 1 , Pages 30-38, January 2011

0

reloj de arena historia 150pxImmunological mechanisms of sublingual allergen-specific immunotherapy
N. Novak, T. Bieber and J.-P. Allam. Allergy. Published online: 20 JAN 2011 | DOI: 10.1111/j.1398-9995.2010.02535.x

0

reloj de arena historia 150pxAdvances in upper airway diseases and allergen immunotherapy
Bradley R. Sabin, Carol A. Saltoun, Pedro C. Avila. Journal of Allergy and Clinical Immunology. Volume 127, Issue 1 , Pages 46-48, January 2011

0

reloj de arena historia 150pxFuture forms of immunotherapy
Thomas B. Casale, Jeffrey R. Stokes. Journal of Allergy and Clinical Immunology. Volume 127, Issue 1 , Pages 8-15, January 2011

0

Health economics of allergen-specific immunotherapy in the United States
Richard F. Lockey, Cheryl S. Hankin
Journal of Allergy and Clinical Immunology Volume 127, Issue 1 , Pages 39-43, January 2011

0

Disease-modifying effect and economic implications of sublingual immunotherapy
Giorgio Walter Canonica, Giovanni Passalacqua
Journal of Allergy and Clinical Immunology. Volume 127, Issue 1 , Pages 44-45, January 2011